These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 21460438)
1. Characterization of amyloid-β granules in the hippocampus of SAMP8 mice. Manich G; Mercader C; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Vilaplana J; Pelegrí C J Alzheimers Dis; 2011; 25(3):535-46. PubMed ID: 21460438 [TBL] [Abstract][Full Text] [Related]
2. Early amyloid accumulation in the hippocampus of SAMP8 mice. Del Valle J; Duran-Vilaregut J; Manich G; Casadesús G; Smith MA; Camins A; Pallàs M; Pelegrí C; Vilaplana J J Alzheimers Dis; 2010; 19(4):1303-15. PubMed ID: 20061609 [TBL] [Abstract][Full Text] [Related]
3. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease. Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743 [TBL] [Abstract][Full Text] [Related]
4. Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model. Dobarro M; Orejana L; Aguirre N; Ramírez MJ Neuropharmacology; 2013 Jan; 64():137-44. PubMed ID: 22824191 [TBL] [Abstract][Full Text] [Related]
5. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896 [TBL] [Abstract][Full Text] [Related]
6. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice. Kern DS; Maclean KN; Jiang H; Synder EY; Sladek JR; Bjugstad KB Cell Transplant; 2011; 20(3):371-9. PubMed ID: 20875225 [TBL] [Abstract][Full Text] [Related]
7. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model. Cheng XR; Zhou WX; Zhang YX Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312 [TBL] [Abstract][Full Text] [Related]
8. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease? Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441 [TBL] [Abstract][Full Text] [Related]
9. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708 [TBL] [Abstract][Full Text] [Related]
10. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody. Chauhan NB; Siegel GJ J Neurosci Res; 2002 Jul; 69(1):10-23. PubMed ID: 12111811 [TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, expression, and regulation of hippocampal amyloid precursor protein of senescence accelerated mouse (SAMP8). Kumar VB; Vyas K; Franko M; Choudhary V; Buddhiraju C; Alvarez J; Morley JE Biochem Cell Biol; 2001; 79(1):57-67. PubMed ID: 11235921 [TBL] [Abstract][Full Text] [Related]
12. Presence of a neo-epitope and absence of amyloid beta and tau protein in degenerative hippocampal granules of aged mice. Manich G; del Valle J; Cabezón I; Camins A; Pallàs M; Pelegrí C; Vilaplana J Age (Dordr); 2014 Feb; 36(1):151-65. PubMed ID: 23867972 [TBL] [Abstract][Full Text] [Related]
13. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease. Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785 [TBL] [Abstract][Full Text] [Related]
14. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Butterfield DA; Poon HF Exp Gerontol; 2005 Oct; 40(10):774-83. PubMed ID: 16026957 [TBL] [Abstract][Full Text] [Related]
15. The activity and mRNA expression of β-secretase, cathepsin D, and cathepsin B in the brain of senescence-accelerated mouse. Zhou JW; Cheng XR; Cheng JP; Zhou WX; Zhang YX J Alzheimers Dis; 2012; 28(2):471-80. PubMed ID: 22008266 [TBL] [Abstract][Full Text] [Related]
16. The difference in gliosis induced by β-amyloid and Tau treatments in astrocyte cultures derived from senescence accelerated and normal mouse strains. Lü L; Mak YT; Fang M; Yew DT Biogerontology; 2009 Dec; 10(6):695-710. PubMed ID: 19221889 [TBL] [Abstract][Full Text] [Related]
17. Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs. Zhang GR; Cheng XR; Zhou WX; Zhang YX Neuroscience; 2009 Mar; 159(1):308-15. PubMed ID: 18721865 [TBL] [Abstract][Full Text] [Related]